Epidemiology of basal cell carcinoma in the United Kingdom: incidence, lifestyle factors, and comorbidities
- PMID: 24874476
- PMCID: PMC4090732
- DOI: 10.1038/bjc.2014.265
Epidemiology of basal cell carcinoma in the United Kingdom: incidence, lifestyle factors, and comorbidities
Abstract
Background: Little is known about the epidemiology of basal cell carcinoma (BCC).
Methods: Using the Clinical Practice Research Datalink, we calculated annual incidence rates. In a case-control analysis, we examined lifestyle factors and comorbidities.
Results: Incidence rose significantly between 2000 and 2011. Basal cell carcinoma risk was increased in alcohol drinkers (slightly) and immunocompromised patients, but reduced in smokers and individuals with abnormal weight.
Conclusions: Basal cell carcinoma places a growing public health burden. Lifestyle factors do not play a major role in pathogenesis, but immunosuppression is important.
Figures
References
-
- Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B. 2001;63 (1-3):8–18. - PubMed
-
- Baxter JM, Patel AN, Varma S. Facial basal cell carcinoma. Br Med J. 2012;345:e5342. - PubMed
-
- Chuang TY, Lewis DA, Spandau DF. Decreased incidence of nonmelanoma skin cancer in patients with type 2 diabetes mellitus using insulin: a pilot study. Br J Dermatol. 2005;153 (3):552–557. - PubMed
-
- Flohil SC, Proby CM, Forrest AD, van Tiel S, Saksela O, Pitkanen S, Ahti T, Micallef R, de Vries E, Group E. Basal cell carcinomas without histological confirmation and their treatment: an audit in four European regions. Br J Dermatol. 2012;167 (Suppl 2):22–28. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
